Chicago: ICAD Offered Mix Bag of Setbacks and Hopeful News
On 31 July, the 11th International Conference on AD drew to a close...
6397 RESULTS
Sort By:
On 31 July, the 11th International Conference on AD drew to a close...
The true prevalence of dementia in developing nations may be higher than is widely believed...
This season might go down in the Alzheimer research history as the summer of calcium...
As with many neurodegenerative diseases, predicting survival time in patients with ALS is a tricky business...
Are oddly behaving placebo groups scuppering clinical trials, or are potential treatments simply not living up to expectation?...
In Alzheimer disease clinical trials, placebo groups seem to be worsening at a more leisurely rate than they once did...
A trio of collaborators has unearthed an unlikely regulator of α-synuclein gene (SNCA) expression...
People affected by early-onset familial forms (eFAD) often wonder how discoveries apply to them...
You can’t do anything about the genome you were born with, but you may be able to change your epigenome...
There is a possibility that the rate of ventricular enlargement over six months could be a useful marker for AD progression...
Two papers in the 19 July Lancet bring both dismay and hope to the ongoing quest for more effective AD treatments...
PBT2, a zinc/copper ligand that may act like an ionophore, shows dramatic effects on cognition in transgenic mouse models of AD...
Presenilins may now have a new claim to fame...
Alternative splicing of messenger RNAs can result in the production of protein isoforms with different functions...
Overproduction seems to be a major problem for neurons...